Pulsatile gonadotropin-releasing hormone therapy in persistent amenorrheic weight-recovered anorexia nervosa patients

Fertil Steril. 2017 Feb;107(2):502-509. doi: 10.1016/j.fertnstert.2016.10.032. Epub 2016 Nov 22.

Abstract

Objective: To compare hormonal and clinical responses to GnRH pulsatile treatment in weight-recovered anorexia nervosa patients (Rec-AN) with persistent functional hypothalamic amenorrhea (HA) vs. in patients with secondary and primary HA.

Design: Retrospective, observational, ambulatory study.

Setting: University hospital.

Patient(s): Forty-one women: 19 Rec-AN (body mass index >18.5 kg/m2 without menses recovery), 15 secondary HA without any eating disorders patients (SHA), and 7 primary HA patients (PHA).

Intervention(s): Gonadotropin-releasing hormone pulsatile therapy.

Main outcome measure(s): Baseline E2, LH, and P plasma levels and their changes during induction cycles; ovulation, follicular recruitment, and pregnancies.

Results: The Rec-AN group displayed higher basal E2 and LH plasma levels after GnRH injection compared with SHA and PHA. Higher E2 and LH levels were observed during induction cycles in Rec-AN compared with SHA and PHA. Follicular recruitment was higher in Rec-AN. The ovulation rate was higher in Rec-AN compared with PHA but similar to SHA.

Conclusion(s): This study showed increased gonadal status and higher E2 response to pulsatile GnRH therapy in persistent amenorrheic weight-recovered AN compared with HA from other causes. It suggests that their individual set-point of body weight allowing a fully functional gonadal axis is not reached yet. Specific factors of gonadal inertia in Rec-AN still remain unclear.

Keywords: Anorexia nervosa; hypothalamic amenorrhea; pulsatile GnRH therapy.

Publication types

  • Comparative Study
  • Observational Study

MeSH terms

  • Adult
  • Amenorrhea / diagnosis
  • Amenorrhea / etiology
  • Amenorrhea / physiopathology
  • Amenorrhea / therapy*
  • Anorexia Nervosa / complications
  • Anorexia Nervosa / diagnosis
  • Anorexia Nervosa / physiopathology
  • Anorexia Nervosa / therapy*
  • Biomarkers / blood
  • Estradiol / blood
  • Female
  • Fertility Agents, Female / administration & dosage*
  • Fertility Agents, Female / adverse effects
  • Gonadotropin-Releasing Hormone / administration & dosage*
  • Gonadotropin-Releasing Hormone / adverse effects
  • Hospitals, University
  • Humans
  • Infusions, Subcutaneous
  • Luteinizing Hormone / blood
  • Menstrual Cycle / drug effects*
  • Ovulation / drug effects
  • Pregnancy
  • Pregnancy Rate
  • Progesterone / blood
  • Pulse Therapy, Drug
  • Recovery of Function
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome
  • Weight Gain*

Substances

  • Biomarkers
  • Fertility Agents, Female
  • Gonadotropin-Releasing Hormone
  • Progesterone
  • Estradiol
  • Luteinizing Hormone